NEWS | March 30, 2022

Sense Neuro Diagnostics Participates in Mayo Clinic and ASU MedTech Accelerator

Multi-Day Immersive Program Intends to Increase Product Quality, Efficiency, and Speed to Market

CINCINNATI, OH – March 30, 2022 – Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, has been selected to participate in the Mayo Clinic and Arizona State University MedTech Accelerator. The flagship program of the Mayo Clinic and ASU Alliance for Health Care was designed to provide early-stage medical device and health care technology companies with an entrepreneurial curriculum and personalized business development plans to accelerate go-to-market and investment possibilities. Eight companies from around the world are participating in the third cohort of this program, which launched March 28, 2022.

The accelerator provides emerging companies with a multi-day immersive curriculum in health care entrepreneurship including lectures and workshops with world-class scientific and engineering experts; resources to navigate regulatory pathways; and tools for product commercialization and customer acquisition. Additionally, participants attend mentoring, business development, and networking events.

“The MedTech Accelerator has a track record of helping medical and healthcare startups achieve success through the partnership they create. Exceptional resources are made available for Sense to assist in technological, clinical and commercial development of our business,” says Geoff Klass, CEO, Sense Neuro Diagnostics. “Sense Neuro is excited for the opportunity to take part in this boot camp and co-develop device and market opportunities with the Mayo Clinic.”

The eight emerging companies, selected for their strong potential for next-generation medical technologies and services, will undergo an immersive curriculum delivered by MedTech Accelerator, followed by 12 months of close collaboration, guidance, and tracking. Follow-up meetings with the MedTech Accelerator team will help Sense Neuro and other startup participants track progress, refine strategy and guide development.

About Sense Neuro Diagnostics
Sense Neuro Diagnostics is focused on improving outcomes for stroke and brain injury patients through technology innovations that enable faster detection and more effective triage. Sense is developing non-invasive technology to enable continuous, real-time brain injury monitoring as well as rapid detection of traumatic brain injury and important stroke subtypes. Learn about the ongoing pivotal trial for continuous monitoring of intracranial hemorrhage, and successful first-inhuman pilot study of triage technology to determine stroke subtype at

About MedTech Accelerator
The MedTech Accelerator is supported by The Mayo Clinic and Arizona State University Alliance for Health Care. The alliance is developing comprehensive improvements in the science of health care delivery and practice, all toward one goal: continually advancing patient care. Together, the recognized world leader in patient care, education and research, and the nation’s No. 1- ranked university for innovation are combining expertise from every corner of health care — doctors to bioengineers to business experts — for an adaptive approach to preparing the next generation of health care pioneers and practitioners in our communities.

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.